Publications
Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
Bone Marrow Transplantation – Yokoyama, Teshima et al (2020)
Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Frontz Pharmacol
– Perez et al (March 2019)
ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent T-Cell Regeneration and Graft-vs.-Tumor Activity Following Experimental Allogeneic Hematopoietic Stem Cell Transplantation
Vollmer, Krenger (2018)
ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent Generation of Autoreactive T Cells during Experimental Acute Graft-vs.-Host Disease
Vollmer and Krenger (2018)
Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic
Hematopoietic Stem Cell Transplantation, Smith & Gergely (September 2017)
S1P signaling: new therapies and opportunities F1000 Prime reports
Gonzales (December 2014)
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Patricia A. Taylor et al (2007)
GVHD prophylaxis with KRP203, a SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, is safe and may have a potential to improve
Poster, Heim et al